The US drug regulator inspected Cadila Healthcare's wholly-owned subsidiary Liva Pharma's injectables manufacturing unit in Vadodara, Gujarat. The inspection was carried on between August 20 to 28.

Vedanta, had proposed entry into the 41 revenue sharing government contracts. Accordingly, the company is bestowed upon 41 exploration blocks in India with a total bid cost of US$ 551 million. The stock of Vedanta opened with a gap-up of nearly Rs. 3 and surged as much as 3.4 per cent in intraday trade.

Following stocks are close to their 52-week low as at 12.55 p.m. on August 29, 2018.

The markets on August 29, 2018 opened gap up. BSE Sensex is trading at 38,876.88, down by 19.75 points and the Nifty is trading at 11,724.20, down by 14.30 points. 

Glenmark Pharmaceuticals Europe has entered into a strategic licensing agreement to market generic Tiotropium Bromide dry powder inhaler (DPI) in Western Europe.

Time Technoplast has tied-up with global specialty chemicals giant Dow for bringing in revolutionary technology-based Smart Cans that enables the transition from large traditional rigid containers to flexible packaging options in the consumer product segment.

The company has been awarded a gas exploration block under the open acreage licensing policy - Round I. The block is located near Hindustan Oil Exploration Company's (HOEC) existing producing field in Dirok, Assam. 

Overall volumes in futures & options currently stand at 1.04 crore contracts with a turnover of Rs. 9,93,882.37 crore.

Overall volumes in futures & options currently stand at 1.04 crore contracts with a turnover of Rs. 9,93,882.37 crore.

Going ahead, the levels of 11,760, followed by 11,800 are likely to act as immediate resistance levels. Stocks in news: Wipro, SBI, Jaiprakash Power Ventures, JMC Projects, Bharat Financial Inclusion and Lakshmi Vilas Bank.